Asset Publisher


SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT)

Pilot Study to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission

SAINT Project Logo
14/05/2020 - 30/08/2020
Carlos Chaccour
Funded by
ISGlobal, Clinica Universidad de Navarra, IDIFARMA

Ivermectin is a widely used drug for the treatment and control of certain neglected tropical diseases. The drug has an excellent safety profile, with more than 2.5 billion doses distributed in the last 30 years. It has proven activity against SARS-CoV-2 in vitro.

For this pilot trial we propose to test the potential of ivermectin to reduce the transmission of the virus. If the results are positive this could be quickly scaled given the known safety profile and robust drug supply.

Help Us Do Research on COVID-19!

If you suspect you might have COVID-19, and:

  • you have symptoms compatible with the disease within the last 48 hours, such as fever, dry cough, headache, and general malaise;
  • you are between 18 and 59 years old; and
  • you live in the Pamplona Basin.

Please, call to the telephone number 628 659 003. In case you are a potential candidate, we will lead you to the ER of the Clínica Universidad de Navarra for a formal visit.

We will stop the new coronavirus together!

More Information:

A Project by:


Supported by:

Our Team

Project Coordinator

  • Carlos Javier Chaccour
    Carlos Javier Chaccour

ISGlobal Team

Other projects

See Past Projects


Combating Bacterial Resistance In Europe


Development of Novel Gastrointestinal Biomarkers for Use in HIV Incidence Determination in a Sub-Saharan African Setting


Combatting Bacterial Resistance in Europe - Carbapenem Resistance


Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women


Integrating and decentralizing diabetes and hypertension services in Africa


Improving Care through Azithromycin Research for Infants in Africa


Predicting the Future: Incipient Tuberculosis


Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19


Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV


Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status


Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring


ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)


Digital Twins Enabled Indoor Air Quality Management for Healthy Living


Community knowledge generation through scientific culture, urban ecology and art


Building Scalable Pathogen Genomic Epidemiology in Ethiopia

Hepatitis C Free Baleares

Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.


Nuevas moléculas de oro coordinadas con flavonoides contra bacterias patógenas multirresistentes prioritarias